Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04134117
Title Tisagenlecleucel In Primary CNS Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Matthew J. Frigault, M.D.
Indications

central nervous system lymphoma

Therapies

Tisagenlecleucel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.